Biomarkers and uterine cervical cancer. Are they useful for prognosis of cancer and triage of precancerous lesions

Abstract Biomarkers are "keys" of oncogenesis. Many applications are soon possible as gene therapy and vaccination. Authors have reviewed different aspects of classical prognosis factors and examined new possibilities of prognosis and selection of precancerous lesions as ASCUS by biomarkers. Ag SCCTA4, HPV typing, microangiogenesis, are the main biomarkers in cervical cancers.